BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16137215)

  • 1. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.
    Trygstad TK; Christensen D; Garmise J; Sullivan R; Wegner S
    J Manag Care Pharm; 2005 Sep; 11(7):575-83. PubMed ID: 16137215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacy management intervention for optimizing drug therapy for nursing home patients.
    Christensen D; Trygstad T; Sullivan R; Garmise J; Wegner SE
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):248-56. PubMed ID: 15903283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications.
    Linton A; Bacon TA; Trice S; Devine J; Cottrell L; McGinnis TJ; McAllister EB
    J Manag Care Pharm; 2010 Oct; 16(8):578-92. PubMed ID: 20866163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
    Trygstad TK; Christensen DB; Wegner SE; Sullivan R; Garmise JM
    Clin Ther; 2009 Sep; 31(9):2018-37. PubMed ID: 19843492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
    Christensen DB; Roth M; Trygstad T; Byrd J
    J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center.
    LaFleur J; McBeth C; Gunning K; Oderda L; Steinvoort C; Oderda GM
    J Manag Care Pharm; 2006 Oct; 12(8):677-85. PubMed ID: 17269846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization.
    Meissner B; Dickson M; Shinogle J; Reeder CE; Belazi D; Senevirante V
    J Manag Care Pharm; 2006 May; 12(4):331-40. PubMed ID: 16792439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an opioid management initiative by a state Medicaid program.
    Garcia MM; Angelini MC; Thomas T; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2014 May; 20(5):447-54. PubMed ID: 24761816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care.
    McMullin ST; Lonergan TP; Rynearson CS
    J Manag Care Pharm; 2005 May; 11(4):322-32. PubMed ID: 15871643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
    Kaur AD; McQueen A; Jan S
    J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.
    Hamer AM; Hartung DM; Haxby DG; Ketchum KL; Pollack DA
    J Manag Care Pharm; 2006; 12(6):449-56. PubMed ID: 16925452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH; Ma J
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG; Huether JR; Handke LJ; Williams CE
    J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data.
    Schneider R; Reinau D; Schur N; Blozik E; Früh M; Signorell A; Meier CR; Schwenkglenks M
    Swiss Med Wkly; 2019 Sep; 149():w20126. PubMed ID: 31568557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.